Wantstats
Company ProfilePremium

Isodiol International Inc.

Company Profile Analysis

Book DemoRegister Your Interest
ESOMAR 23 Corporate BadgeISO Certifications Badge
Isodiol International Inc. - Healthcare showcase

Year Founded & Workforce

2014

30 Employees

Industry

Healthcare

Services

CBD Hemp OilCannabidiol Market
I

Isodiol International Inc. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Isodiol International Inc. Overview

Company Headquarters: California, US

Founded: 2014

Workforce: ~30

Company Working: Isodiol International Inc. is a leader in pharmaceutical grade phytochemical compounds and an industry leader in the manufacturing and development of consumer products. The company has commercialized naturally isolated CBD with micro-encapsulation and nanotechnology to develop quality consumable and topical skincare products. It offers supplements, vitamins, pharmaceuticals, and various nutraceutical products. The company’s product range involves daily products, CBD pet products, CBD sport products, and skin care products.

Strategy

Isodiol International Inc. is focused on the expansion of over the counter and pharmaceutical drugs. It also includes the expansion of its phytoceutical portfolio and business internationally into Latin America, Europe, and Asia. The company is collaborating with partners worldwide to supply industrial hemp derivatives for medicinal formulations in the cosmetic, nutraceutical, and pharmaceutical markets.

Company Snapshot

$0.01M

Revenue

30

Employees

2014

Founded

California, US

Headquarters

SWOT Analysis

Strengths

  • Strong relationships with investors
  • Specializing in the development of CBD-based pharmaceutical and nutraceutical products
  • Binding agreements with hemp cultivators
  • Highest quality CBD products
  • Strong customer base
  • GMP certficed manufacturing facilities

Weaknesses

  • Limited supply of innovative products
  • Costly products
  • Less focus on emerging markets such as Asia-Pacific
  • Less R&D investment

Opportunities

  • Geographical expansion
  • Government approval for utilizing natural CBD as an active pharmaceutical ingredient (API)
  • Strategic collaborations with pharmaceutical companies
  • Growth in the CBD market worldwide

Threats

  • Presence of established players in the market
  • Stringent government regulations
  • Growing competition in the market

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
December 2018AcquisitionIsodiol International Inc. announced the acquisition of Food Labs, Inc. and strategic investor relationship with Toba Capital LLC.

Product Offering

  • Isodiol International Inc.
    • CBD Hemp Oil
    • Cannabidiol Market

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Global Sales rose from USD 0 Mn in 2016 to USD 14.1 Mn in 2018.
Isodiol International Inc. — By Business Segment
Series (USD Mn)201620172018
Global Sales00.314.1
R&D Expenditure00.10.5

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.

Get Contacts →